NIPH – Turnaround Momentum vs. Valuation Reality El-Nile Co. for Pharmaceuticals & Chemical IndustriesEGX_DLY:NIPHmnmabroukw36ixNIPH – Turnaround Momentum vs. Valuation Reality 📉💊 The Reality: An incredible "Turnaround Story" with a massive 155% leap in net profits (reaching EGP 170.1M). 📈 Revenue surged 114%, but don't ignore the low cash conversion (45%). Much of this "profit" is tied up in inventory revaluation and hospital receivables rather than liquid cash in the bank. 💸🕳️ The Valuation Trap: At a P/E of 22.3x, NIPH is trading at a massive premium compared to the sector giant PHAR (EIPICO), which trades at ~10x. 🤡 You are paying a high price for a public-sector recovery while a high-quality export leader like EIPICO is significantly cheaper. Expect the "Smart Money" to eventually rotate out of this valuation gap. 🔄💰 The Strategy: The technicals are screaming "Overbought." 🚨 We have a floating candle outside the Bollinger Bands, signaling an imminent pullback. Having reached the 133.30 target, a push to the 145.00 ATH is possible but risky. Profit-taking is coming watch for a drop to the 121.00 minor support or the 108.00 fair value floor. 🧗♂️📉 Sharia Status: ❌ Non-Compliant. NIPH fails the quantitative screens for the EGX33 Shariah Index (April 2026). The primary culprit is non-permissible interest income from cash reserves exceeding the 5% threshold and high public-sector receivables. ☪️🚫 Verdict: High-Velocity, High-Risk. The turnaround is real, but the price has outpaced the fundamental quality. Don't chase the floating candle wait for the rotation or the pullback. 🛡️⚖️ If you like my posts, please follow and boost 🙌 🎁 Get a $15 discount on your next subscription: 🔗 https://www.tradingview.com/pricing/?share_your_love=mnmabroukw36ix ✨💸